AFP and hepatocellular carcinoma: Of the 76 HCC sera, 62 were tested for the presence of both the anti-NPM1 autoantibody and AFP; 38 sera (61.3%) had an AFP level >100 ng/ml, and 15 sera (24.2%) were positive for the anti-NPM1 autoantibody.